As seen online:
“Andrew Chan, Consultant Clinical Oncologist at UHCW NHS Trust, says data from the trial, which has involved more than 870 prostate cancer patients across the world, is very encouraging. “This is a pivotal, practice-changing result because it means that for this highly prevalent cancer we are able to reduce radiotherapy treatment to only a quarter of the current standard – from 20 days to five days – with the same clinical benefits,” he said. “That would be such a game changer for both patients and for the NHS in terms of less visits to hospital so patients can return to their usual activities quicker than normal and it generates more capacity for treatment.””
— from Trial shows new radiotherapy treatment could benefit prostate cancer patients - University Hospitals Coventry & Warwickshire as of 29 June 2026